Literature DB >> 1762814

Consensus and contention in the treatment of chronic nerve-damage pain.

Huw T O Davies1, Iain K Crombie, Margaret Lonsdale, William A Macrae.   

Abstract

A postal questionnaire survey was carried out to investigate beliefs in the efficacy of specific treatments held by consultants involved in the treatment of chronic nerve-damage pain. One hundred eighty-eight consultants experienced in the treatment of chronic pain were identified by local Pain Clinic consultants in 5 centres. The specialties represented were neurology, neurosurgery, orthopaedic surgery, oncology/radiotherapy, plastic surgery and anaesthesia. Replies were received from 181 consultants (96%). Over one fifth of the consultants expressed no opinion about half of the treatments assessed. Widely divergent views were held by those who did give an opinion. Many clinicians assessed some treatments as 'poor' while other clinicians assessed the same treatments as 'excellent' (neurolytic nerve block, somatic nerve block, cordotomy and opioids). For some treatments divergence of opinion can be explained in part by differences between specialties. For other treatments marked diversity was seen within as well as between specialties. There is a clear need for education in the use of particular treatments, even amongst those clinicians who regularly see this type of patient.

Entities:  

Mesh:

Year:  1991        PMID: 1762814     DOI: 10.1016/0304-3959(91)90204-B

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

1.  Bioassay-guided evaluation of antinociceptive effect of N-salicyloyltryptamine: a behavioral and electrophysiological approach.

Authors:  Lucindo J Quintans; Davi A Silva; Jullyana S Siqueira; Adriano A S Araújo; Rosana S S Barreto; Leonardo R Bonjardim; Josimari M Desantana; Waldeci De Lucca; Maria F V Souza; Stanley J C Gutierrez; José Maria Barbosa-Filho; Valter J Santana-Filho; Demétrius A M Araújo; Reinaldo N Almeida
Journal:  J Biomed Biotechnol       Date:  2010-10-05

2.  [Prevalence and characteristics of neuropathic pain in malignant disease.].

Authors:  S Grond; D Zech; T Meuser; L Radbruch; M Kasper; K A Lehmann
Journal:  Schmerz       Date:  1992-06       Impact factor: 1.107

3.  Entering the loop: assessing the contribution of pain clinics in northern Britain.

Authors:  I K Crombie; H T Davies; W A Macrae
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

4.  Why use a pain clinic? Management of neurogenic pain before and after referral.

Authors:  H T Davies; I K Crombie; W A Macrae
Journal:  J R Soc Med       Date:  1994-07       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.